Tablets & Capsules

TC0615

Issue link: https://www.e-digitaleditions.com/i/525960

Contents of this Issue

Navigation

Page 26 of 131

Tablets & Capsules Solid Dosage SourceBook June 2015 25 Capsugel 535 N. Emerald Rd. Greenwood, SC 29646 Tel: 888 783 6361 800 845 6973 Email: solutions@capsugel.com Website: www.capsugel.com Major Products and Services From hard gelatin, liquid-filled and vegetarian capsules, to product development, equipment and commercial manufacturing services, we help our customers improve their product profiles and accelerate development and commercialization timelines. Capsugel DFS accelerates and improves product development through an array of proprietary technologies including lipids and liquids, spray-dried dispersions, hot-melt extrusions, and through specialized manufacturing including FDA-and MHRA-accredited finished dosage sites that can handle highly potent, controlled substance, hormonal, and oncology compounds. Facilities Our customers span the globe, and Capsugel's manufacturing and business centers do as well. With multiple production and business facilities worldwide, Capsugel is able to offer an unmatched certainty of supply, ensuring your capsules are where you need them, when you need them. Capsugel is headquartered in Morristown, NJ, employs 2,900 people, has 12 manufacturing and R&D facilities across three continents and serves more than 4,000 customers in over a 100 countries. Corporate Description Capsugel is a global leader in delivering high-quality, innovative dosage forms and solutions to its customers in the health care industry. With more than 100 years of experience, we provide a comprehensive array of advanced solutions to pharmaceutical and nutritional customers from formulation through clinical and commercial supply. The company's Hard Capsule business unit offers customers the broadest portfolio of gelatin, vegetarian, and other specialized capsule technologies. Capsugel's Dosage Form Solutions (DFS) business unit solves customers' most pressing product development challenges, including bioavailability enhancement, modified release, abuse deterrence, biotherapeutic processing, and inhalation formulation. Capsugel

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0615